Stay updated with breaking news from Nasdaq Prtk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday. Several other equities research analysts have also recently issued reports on PRTK. BTIG Research cut their target price on Paratek Pharmaceuticals from $24.00 to $5.00 in a research note […]
StockNews.com downgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a hold rating in a report issued on Saturday. Other equities research analysts have also recently issued reports about the company. HC Wainwright lowered their target price on Paratek Pharmaceuticals from $10.00 to $6.00 in a research note on Wednesday, […]
StockNews.com lowered shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Saturday. Several other equities research analysts also recently commented on PRTK. BTIG Research decreased their price objective on Paratek Pharmaceuticals from $24.00 to $5.00 in a report on Tuesday, […]
Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) had its price objective cut by HC Wainwright from $10.00 to $6.00 in a research note published on Wednesday, The Fly reports. HC Wainwright also issued estimates for Paratek Pharmaceuticals’ Q2 2023 earnings at ($0.30) EPS, Q3 2023 earnings at ($0.24) EPS, Q4 2023 earnings at ($0.19) EPS, FY2023 […]
Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday. A number of other equities research analysts have also recently commented on PRTK. HC Wainwright dropped their price objective on shares of Paratek […]